Gate Neurosciences is on a mission to develop a new generation of therapies for the hundreds of millions of people worldwide suffering from neuropsychiatric and cognitive disorders. We are dedicated to advancing novel, safe, and rapid-acting drug mechanisms that address underlying disease biology by enhancing synaptic function, strengthening neuronal connections, and restoring healthy brain signaling. Our approach focuses on precision psychiatry and evidence-driven insights, and is based on learnings from extensive clinical, preclinical, and translational data across thousands of patients with our molecules. By rethinking what’s possible, we’re creating hope for better mental health treatments and better lives. To learn more about our clinical-stage, next-generation neuroscience pipeline, please visit our website: https://www.gateneuro.com
